Hadassah

Hadassah/Jerusalem Project Inspires UN and Africans to Reduce Spread of AIDS Through Circumcisions

Sunday, Jan 15 2012

Inspired by the Israeli Operation Abraham circumcision project, the United Nations and United States Government are spearheading a program to circumcise 20 million African men over the next five years to help reduce the spread of AIDS.

Circumcision, according to UN data, can reduce the risk of HIV infection by 60 percent. On the heels of Israel's success with circumcising about 100,000 new immigrants from Russia and Ethiopia, Operation Abraham was founded in May 2007 as a collaboration between the Hadassah University Medical Center and the Jerusalem AIDS Project (JAIP). Its first initiative, named "Operation AB" and conducted in Swaziland, marked the beginning of international collaboration in Africa in the area of male circumcision. Operation AB established, pilot tested, and gave shape to a community, clinic-based model for male circumcision training and service delivery.

A delegation of Israeli circumcisors (mohalim) went to Africa at the end of November to help the UN construct medical protocols for this new, broader initiative. Read The Jerusalem Post article.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More